Drug Pipeline

Post-Transplant Cyclophosphamide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
7
Active Studies
4
Recruiting
5
Top Sponsors
Active Studies by Phase
Phase 2
7
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06252870 Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by… Graft Versus Host Disease Recruiting
NCT06859424 A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based… AML (Acute Myelogenous Leukemia) Recruiting
NCT07214688 Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo… Allogeneic Stem Cell Transplant Recipient Recruiting
NCT05027945 A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS… Immunodeficiency Recruiting
NCT06001385 HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced… Acute Lymphoblastic Leukemia Active, Not Recruiting
NCT04904588 HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With… Acute Lymphoblastic Leukemia Active, Not Recruiting
NCT05907746 Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in… GATA2 Active, Not Recruiting
Sponsors Running Post-Transplant Cyclophosphamide Trials
Disease Areas
Get alerts when Post-Transplant Cyclophosphamide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free